Evidence map›Paper›PMID 30833553›Full record

ArticleNature communications2019

Molecular constraints on CDR3 for thymic selection of MHC-restricted TCRs from a random pre-selection repertoire.

Jinghua Lu, François Van Laethem, Abhisek Bhattacharya, Marco Craveiro, Ingrid Saba, Jonathan Chu, Nicholas C Love, Anastasia Tikhonova, Sergei Radaev, Xiaoping Sun and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Jinghua LuStructural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, MD, 20852, USA.
François Van LaethemExperimental Immunology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.
Abhisek BhattacharyaExperimental Immunology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.
Marco CraveiroExperimental Immunology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.ORCID http://orcid.org/0000-0002-7405-4621
Ingrid SabaExperimental Immunology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.
Jonathan ChuStructural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, MD, 20852, USA.
Nicholas C LoveExperimental Immunology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.
Anastasia TikhonovaExperimental Immunology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.
Sergei RadaevStructural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, MD, 20852, USA.
Xiaoping SunLymphocyte Differentiation Section, Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institute of Health, Baltimore, MD, 21224, USA.
Annette KoLymphocyte Differentiation Section, Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institute of Health, Baltimore, MD, 21224, USA.
Tomer ArnonDepartment of Immunology, Weizmann Institute of Science, 76100, Rehovot, Israel.
Eric ShifrutDepartment of Immunology, Weizmann Institute of Science, 76100, Rehovot, Israel.
Nir FriedmanDepartment of Immunology, Weizmann Institute of Science, 76100, Rehovot, Israel.ORCID http://orcid.org/0000-0002-1078-3921
Nan-Ping WengLymphocyte Differentiation Section, Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institute of Health, Baltimore, MD, 21224, USA.
Alfred SingerExperimental Immunology Branch, National Cancer Institute, Bethesda, MD, 20892, USA. singera@nih.gov.
Peter D SunStructural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, MD, 20852, USA. psun@nih.gov.
National Cancer Institute · USNational Institute of Allergy and Infectious Diseases · USNational Institute on Aging · USWeizmann Institute of Science · ILAlfred University · US

Funding

University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
Structural Characterization Of ProteinsZIAAI000697 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SUN, PETER D. · 2009 to 2025
$12.3M
MHC-independent T cellsZIABC011116 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, ALFRED · 2009 to 2025
$12.3M
TCR repertoire: size, diversity, and functionZIAAG000499 · NIA · NATIONAL INSTITUTE ON AGING · PI WENG, NAN-PING PETER · 2017 to 2025
$3.6M
NIGMS NIH HHS T32 GM007266
6 · The paper itself

Abstract

The αβ T cell receptor (TCR) repertoire on mature T cells is selected in the thymus, but the basis for thymic selection of MHC-restricted TCRs from a randomly generated pre-selection repertoire is not known. Here we perform comparative repertoire sequence analyses of pre-selection and post-selection TCR from multiple MHC-sufficient and MHC-deficient mouse strains, and find that MHC-restricted and MHC-independent TCRs are primarily distinguished by features in their non-germline CDR3 regions, with many pre-selection CDR3 sequences not compatible with MHC-binding. Thymic selection of MHC-independent TCR is largely unconstrained, but the selection of MHC-specific TCR is restricted by both CDR3 length and specific amino acid usage. MHC-restriction disfavors TCR with CDR3 longer than 13 amino acids, limits positively charged and hydrophobic amino acids in CDR3β, and clonally deletes TCRs with cysteines in their CDR3 peptide-binding regions. Together, these MHC-imposed structural constraints form the basis to shape VDJ recombination sequences into MHC-restricted repertoires.

Indexed as

Amino Acid SequenceAnimalsComplementarity Determining RegionsLymphocyte ActivationMajor Histocompatibility ComplexMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutReceptors, Antigen, T-CellSequence Analysis, ProteinThymus GlandT-LymphocytesV(D)J RecombinationComplementarity Determining RegionsReceptors, Antigen, T-Cell

Identifiers

PMID30833553
PMCPMC6399321
OpenAlexW2918223405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.